Transgene S.A.
TNG.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €79 | €139 | €165 | €231 |
| - Cash | €17 | €16 | €4 | €6 |
| + Debt | €10 | €1 | €2 | €4 |
| Enterprise Value | €73 | €125 | €163 | €229 |
| Revenue | €6 | €8 | €3 | €10 |
| % Growth | -19.6% | 152.7% | -68.7% | – |
| Gross Profit | -€28 | -€22 | -€29 | -€23 |
| % Margin | -439.6% | -274.5% | -929% | -229.1% |
| EBITDA | -€27 | -€28 | -€30 | -€24 |
| % Margin | -419.5% | -360% | -970.2% | -235.7% |
| Net Income | -€34 | -€22 | -€33 | -€20 |
| % Margin | -534.7% | -282.6% | -1,049.6% | -200.2% |
| EPS Diluted | -0.29 | -0.22 | -0.33 | -0.22 |
| % Growth | -31.8% | 33.3% | -50% | – |
| Operating Cash Flow | -€24 | -€35 | -€20 | -€32 |
| Capital Expenditures | -€3 | -€3 | -€2 | -€1 |
| Free Cash Flow | -€27 | -€37 | -€22 | -€33 |